Silica-phenolic hybrid nanocarriers in redox oncology: interfacial mechanisms and translational barriers - Research
Plant-derived phenolic compounds are attractive redox-active agents in oncology because they can reshape oxidative stress and redox signaling; however, clinical translation remains limited by low solubility, instability, rapid metabolism, and insufficient tumor exposure. Mesoporous silica nanoparticles (MSNs) offer a modular scaffold that can stabilize phenolics, tune spatiotemporal release, and…













